Alpha Teknova, Inc. (TKNO)


-0.20 (-3.31%)
Symbol TKNO
Price $5.84
Beta 0.000
Volume Avg. 0.05M
Market Cap 164.282M
Shares () -
52 Week Range 3.02-18.344
1y Target Est -
DCF Unlevered TKNO DCF ->
DCF Levered TKNO LDCF ->
ROE -28.69% Sell
ROA -23.60% Sell
Operating Margin -
Debt / Equity 43.11% Neutral
P/E -
P/B 1.46 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest TKNO news

Mr. Stephen Gunstream
Drug Manufacturers—Specialty & Generic
NASDAQ Global Market

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.